z-logo
Premium
Cyclosporine drug monitoring with C0 and C2 concentrations in children with stable renal allograft function
Author(s) -
Kalyoncu Mukaddes,
Topaloglu Rezan,
Bayrakci Umut,
Bakkaloglu Aysin,
Besbas Nesrin,
Ozaltin Fatih,
Bakkaloglu Mehmet
Publication year - 2006
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2005.00436.x
Subject(s) - medicine , renal function , drug , therapeutic drug monitoring , urology , pharmacology , intensive care medicine
Abstract:  Cyclosporin A (CsA) has a narrow therapeutic window and necessitates monitoring of blood concentration. We aimed to evaluate trough (C0) and second hour (C2) level after ingestion of drug monitoring in renal allograft recipients. In this retrospective study, 12 children eight boys and four girls; mean age at transplantation 14.6 ± 3.7 yr (ranges: 7.0–19.0), mean age post‐transtplant 17.8 ± 4.9 yr (ranges: 9.0–24.0) who were transplanted >6 months were enrolled in this evaluation. Ten were recipients of a living related donor and two deceased donor grafts. While six children were receiving CsA, steroids and azathioprine, the other six received CsA, steroids and mycophenolate mofetil. Clinical course, blood pressure, renal and liver function tests were recorded. Mean C0 and C2 were 96.2 ± 59.5 and 504 ± 305.4 ng/mL respectively. Mean serum creatinine level was 1.2 ± 0.45 mg/dL and mean creatinine clearance (CrCl) was 89.2 ± 36.8 mL/min/1.73 m 2 . There was a correlation between serum creatinine level, CsA dose and C2 levels,whereas,there was no correlation between age, blood pressure, CrCl and C2 levels. However, no correlation was found between C0 levels and any of the above parameters. In conclusion, our data suggest that C2 levels are correlated better with dose and serum creatinine level.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here